Obstacles to the Implementation of Antiemetic Guidelines

被引:21
作者
Grunberg, Steven M. [1 ]
机构
[1] Univ Vermont, Coll Med, Div Hematol Oncol, Burlington, VT 05405 USA
来源
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2009年 / 7卷 / 05期
关键词
Guidelines; vomiting; nausea; antiemetics; CHEMOTHERAPY-INDUCED NAUSEA; CLINICAL GUIDELINES; AMERICAN-SOCIETY; CANCER; HEALTH; GUIDANCE; FEEDBACK; ONCOLOGY; NICE;
D O I
10.6004/jnccn.2009.0040
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although guidelines help physicians deliver high quality clinical care, they will have minimal impact unless familiarity and adherence are achieved. Although nausea and vomiting are highly feared toxicities of chemotherapy that markedly decrease patient quality of life, modifications in physician behavior and improvements in standards of care, particularly in terms of preventing delayed emesis, have been slow. Variations in format, goals, physician education, and institutional education may all affect guideline implementation and state-of-the-art care. The relationship between these factors and the scientific basis of antiemetic guidelines must be considered to achieve optimal results and compliance. (JNCCN 2009;7:601-605)
引用
收藏
页码:601 / 605
页数:5
相关论文
共 36 条
[1]  
[Anonymous], 1999, AM J HEALTH-SYST PH, V56, P729
[2]  
[Anonymous], 2003, PIRATES CARIBBEAN CU
[3]   Antiemetic prescription in Italian breast cancer patients submitted to adjuvant chemotherapy [J].
Ballatori, E ;
Ruggeri, B ;
De Angelis, V ;
Patoia, L ;
Palazzo, S ;
Cinieri, S .
SUPPORTIVE CARE IN CANCER, 2003, 11 (12) :785-789
[4]   COST-REDUCING TREATMENT ALGORITHMS FOR ANTINEOPLASTIC DRUG-INDUCED NAUSEA AND VOMITING [J].
BERARD, CM ;
MAHONEY, CD .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (17) :1879-1885
[5]  
Burgers JS, 2003, BRIT J GEN PRACT, V53, P15
[6]   ON THE RECEIVING END PATIENT PERCEPTION OF THE SIDE-EFFECTS OF CANCER-CHEMOTHERAPY [J].
COATES, A ;
ABRAHAM, S ;
KAYE, SB ;
SOWERBUTTS, T ;
FREWIN, C ;
FOX, RM ;
TATTERSALL, MHN .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (02) :203-208
[7]  
DeAngelis V, 2003, P AN M AM SOC CLIN, V22, P739
[8]  
Del Favero A, 1998, ANN ONCOL, V9, P759
[9]  
Engstrom C, 1999, Oncol Nurs Forum, V26, P1453
[10]  
Ettinger David S, 2007, J Natl Compr Canc Netw, V5, P12